Mawson Infrastructure Group Files 8-K

TL;DR

Mawson Infra (MIGI) filed an 8-K on 12/10/24. Check it for updates.

AI Summary

Mawson Infrastructure Group Inc. filed an 8-K on December 10, 2024, reporting other events and financial statements. The company, formerly known as Wize Pharma, Inc., OphthaliX, Inc., and DENALI CONCRETE MANAGEMENT INC, is incorporated in Delaware and headquartered in Midland, Pennsylvania.

Why It Matters

This filing indicates a routine update or disclosure from Mawson Infrastructure Group Inc., which may contain important information for investors regarding the company's operations or financial status.

Risk Assessment

Risk Level: low — This is a standard 8-K filing for reporting events and financial statements, not indicating any immediate or significant new risks.

Key Players & Entities

• Mawson Infrastructure Group Inc. (company) — Registrant
• Wize Pharma, Inc. (company) — Former Company Name
• OphthaliX, Inc. (company) — Former Company Name
• DENALI CONCRETE MANAGEMENT INC (company) — Former Company Name
• December 10, 2024 (date) — Date of Report

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 par value MIGI The Nasdaq Stock Market

Filing Documents

• f8k_121024.htm (8-K) — 16KB
• exh_991.htm (EX-99.1) — 8KB
• 0001171843-24-006869.txt ( ) — 222KB
• gnw-20190101.xsd (EX-101.SCH) — 3KB
• gnw-20190101_def.xml (EX-101.DEF) — 25KB
• gnw-20190101_lab.xml (EX-101.LAB) — 33KB
• gnw-20190101_pre.xml (EX-101.PRE) — 22KB
• f8k_121024_htm.xml (XML) — 3KB

01. Other Events

Item 8.01. Other Events. On December 10, 2024, Mawson Infrastructure Group Inc. (the "Company") issued a press release announcing its unaudited business and operational update for November 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated December 10, 2024 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS The Company cautions that statements in this filing that are not a description of historical fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words referencing future events or circumstances such as "expect," "intend," "plan," "anticipate," "believe," and "will," among others. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" included in the Company's Annual Report on Form 10-K filed with the SEC on April 1, 2024, Quarterly Report on Form 10-Q filed with the SEC on May 15, 2024, August 19, 2024, November 14, 2024, the Report on Form 8-K filed with the SEC on December 4, 2024, and in other filings that the Company has made and may make with the SEC in the future. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. The Company undertakes no obli

View Full Filing

View this 8-K filing on SEC EDGAR